ExclUsive endocRine Therapy Or Partial Breast Irradiation for Women Aged ≥70 Years With Luminal-A Early Stage Breast Cancer (EUROPA)
Condition: Breast Cancer Interventions: Radiation: Partial Breast Irradiation (PBI); Drug: Endocrine Therapy (ET): letrozole, anastrozole, exemestane, tamoxifen Sponsors: Azienda Ospedaliero-Universitaria Careggi; Institut Curie; University of Florence Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Arimidex | Breast Cancer | Cancer | Cancer & Oncology | Endocrine Therapy | Research | Tamoxifen | Women